Bryan Irving
Corporate Officer/Principal bei 3T Biosciences, Inc.
Ursprung des Netzwerks ersten Grades von Bryan Irving
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 11 | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA.
8
| Subsidiary | Biotechnology | 8 |
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology 3T Biosciences, Inc. operates as immunotherapy company. The company was founded by Luke J. Lee, Marvin Gee and Leah Sibener and is headquartered in Palo Alto, CA.
6
| Holding Company | Biotechnology | 6 |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bryan Irving
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Human Resources Officer | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Chairman Director/Board Member | |
| IQVIA HOLDINGS INC. | Services to the Health Industry | Director/Board Member Director/Board Member | |
| Golden Gate University | College/University | Masters Business Admin Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| SOLARCITY CORP | Building Products | Director of Finance/CFO | |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
| PREDICTIVE ONCOLOGY INC. | Medical Specialties | Director/Board Member | |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Corporate Officer/Principal | |
One Planet VC LLC
 One Planet VC LLC Investment ManagersFinance One Planet VC LLC (One Planet VC) is a venture capital firm subsidiary of One Planet Group Inc founded in 2015 by Payam Zamani. The firm is headquartered in Walnut creek, California. | Investment Managers | Director of Finance/CFO | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Chief Operating Officer | |
Digital Island, Inc.
 Digital Island, Inc. Internet Software/ServicesTechnology Services Digital Island, Inc. provides network services for e-business applications. The company is based in San Francisco, CA and has subsidiaries in the United States. | Internet Software/Services | Director of Finance/CFO | |
| Harvard College | College/University | Undergraduate Degree | |
| Cable & Wireless, Inc. | Director of Finance/CFO | ||
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
Casdin Capital /Private Equity/
 Casdin Capital /Private Equity/ Investment ManagersFinance Casdin Capital /Private Equity/ (Casdin Capital) is a private equity/venture capital subsidiary of Casdin Capital LLC founded in 2012 by Eli Casdin. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Cable & Wireless Ltd.
 Cable & Wireless Ltd. Major TelecommunicationsCommunications Cable & Wireless Ltd. operates as a telecommunications company. The company was founded in 1929 and is headquartered in London, the United Kingdom. | Major Telecommunications | Director of Finance/CFO | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Investment Managers | Founder | |
Precision Medicine Group LLC
 Precision Medicine Group LLC Miscellaneous Commercial ServicesCommercial Services Precision Medicine Group LLC engages in the provision of an integrated infrastructure that supports pharmaceutical and life sciences companies. It offers translational informatics and biometrics, specialty lab, biomaterials, oncology, and diagnostics and medical device solutions. The company was founded by Ethan D. Leder and Mark P. Clein in 2012 and is headquartered in Bethesda, MD. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 3 |
| Italien | 2 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 23 |
| Finance | 8 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Producer Manufacturing | 3 |
Operativ
| Director/Board Member | 148 |
| Corporate Officer/Principal | 70 |
| Independent Dir/Board Member | 48 |
| Director of Finance/CFO | 28 |
| Chief Tech/Sci/R&D Officer | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Mark McDade | 35 |
| Shelley Chu | 31 |
| David Hirsch | 20 |
| Rachel Humphrey | 17 |
| David Smith | 17 |
| John Leonard | 17 |
| Krishna R. Polu | 16 |
| Linda Rubinstein | 16 |
| Ciara Kennedy | 15 |
| Angie You | 15 |
| Carol Schafer | 13 |
| Marc Belsky | 11 |
| Sean E. Harper | 11 |
| David White | 10 |
- Börse
- Insiders
- Bryan Irving
- Unternehmensverbindungen
